MS Contin Addiction News

Table of Contents Latest News and Details on MS Contin Addiction, Abuse and Detox Prevalence of Contin Abuse and Addiction Symptoms of Contin Withdrawal References and Resources Latest News and Details on MS Contin Addiction, Abuse and Detox Morphine is a non-synthetic prescription opioid drug that many other narcotics are modeled off or made from.…

Luminal Addiction News

Table of Contents News And Facts:Luminal Use, Abuse, Addiction and Side Effects What Is Luminal Used For? Information On  Luminal Addiction Signs References and Resources News And Facts :Luminal Use, Abuse, Addiction and Side Effects There has been a considerable increase in prescription drug abuse and addiction during the past decade. Prescription drug misuse can…

Ludiomil Addiction and Abuse News

Table of Contents Reports On  Ludiomil Use and Addiction  Ludiomil Usage Ways Of Preventing Ludiomil Addiction Side Effects of Ludiomil Use and Abuse References and Resources Reports On Ludiomil Use and Addiction Antidepressant medications are used to treat various conditions, including depression and other mental and mood disorders. These medications can help prevent suicidal thoughts…

Kadian Addiction News

Table of Contents Kadian Use and Addiction News: FDA Regulations, Abuse and Effects References and Resources The FDA approved generic equivalents of the Kadian®, a product brand name, in November 2011. The drug is an extended-release morphine product manufactured by Actavis Elizabeth LLC. Even though the commercial introduction of a new generic formulation is perhaps…

Hydrocodone Addiction News

Table of Contents Classification of Hydrocodone as a Schedule II Drug Updates On Changes in Hydrocodone Prescribing Practices Hydrocodone Addiction News Reports On Signs of Success References and Resources Classification of Hydrocodone as a Schedule II Drug In October 2014, The DEA changed hydrocodone combination analgesics from Schedule III of the Controlled Substances Act to…

Horizant Addiction News

Table of Contents FDA Approves Horizant Extended Release Tablets for the Treatment of Restless Legs Syndrome References and Resources FDA Approves Horizant Extended Release Tablets for the Treatment of Restless Legs Syndrome The FDA has approved a new drug, Horizant Extended-Release Tablets, for once a day use in treatment for moderate to severe cases of…

Doral Use and Addiction News

Table of Contents The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices References and Resources The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices The US Food and Drug Administration (FDA), and the Office of Prescription Drug Promotion (OPDP) sent a Warning Letter to Galt Pharmaceuticals LLC concerning its…

Hysingla ER Abuse and Addiction – Latest News

The FDA Approves Abuse-Deterrent Hydrocodone Pill The FDA has given the go-ahead to Hysingla ER (hydrocodone bitartrate, Purdue Pharma), an extended-release opioid analgesic to manage pain severe enough to require long-term, daily, around-the-clock opioid treatment and for which alternative treatment options are inadequate around-the-clock, long-term. Hysingla ER has qualities that are expected to reduce, but…